Hpv vaccine

1. Hpv vaccine decreases HPV45 prevalence in humans (-84% (95% CI 73-90%)).

   Humansfemales

   Impact of HPV vaccination on high-risk HPV prevalence in 25-29-year-old women attending cervical screening in England 2016-2025 · medRxiv · 29 Sep 2026 · Preprint

1. Hpv vaccine decreases HPV31 prevalence in humans (-85% (95% CI 72-92%)).

   Humansfemales

   Impact of HPV vaccination on high-risk HPV prevalence in 25-29-year-old women attending cervical screening in England 2016-2025 · medRxiv · 29 Sep 2026 · Preprint

1. Hpv vaccine decreases HPV18 prevalence in humans (-84% (95% CI 65-93%)).

   Humansroutine-eligible vs vaccination-ineligiblefemales

   Impact of HPV vaccination on high-risk HPV prevalence in 25-29-year-old women attending cervical screening in England 2016-2025 · medRxiv · 29 Sep 2026 · Preprint

1. Hpv vaccine decreases HPV16 prevalence in humans (-91% (95% CI 87-94%)).

   Humansroutine-eligible vs vaccination-ineligiblefemales

   Impact of HPV vaccination on high-risk HPV prevalence in 25-29-year-old women attending cervical screening in England 2016-2025 · medRxiv · 29 Sep 2026 · Preprint

1. Hpv vaccine lowers the risk of cervical cancer in silico (1.82 million cases averted (53% reduction)).

   “Continuation of Nigeria's current adolescent program is projected to avert 1.82 million cervical cancer cases (IQR 1.65-1.90 million; 95% UI 1.39-2.02 million) over 2025-2100 (a 53% reduction relative to no vaccination”

   In silico2025-2100

   Model-based evaluation of an infant HPV prophylactic vaccination program in Nigeria · medRxiv · 2 Oct 2026 · Preprint

2. Hpv vaccine lowers the risk of cervical cancer in humans.

   Reviewfemales

   Human Papillomavirus (HPV) and Cervical Cancer: An Exploratory Systematic Review of Heterogeneous Evidence on Epidemiology, Vaccination, Screening, and Molecular Advances · Cancer investigation · 29 Sep 2026

Cervical cancer →